Prostate Protection Formula™
Prostate Protection Formula™ contains plant-based ingredients that support prostate health and relieve urinary symptoms. I3C, DIM and curcumin extracts support the detoxification pathways of the liver, beta-sitosterol improves urinary symptoms and lycopene and selenium have protective antioxidant effects.
Prostate Protection Formula™ contains plant-based ingredients that support prostate health and relieve urinary symptoms. I3C, DIM and curcumin extracts support the detoxification pathways of the liver important in removing harmful metabolites. Beta-sitosterol supports urinary flow and frequency of urination and may protect against the harmful effects of excessive inflammation. Higher levels of lycopene and selenium have been positively associated with prostate health. With added piperine for enhanced absorption.
Each capsule contains the following active ingredients:
|I3C (Indole-3-carbinol cruciferous vegetable extract)||50mg|
|DIM (Di-indole-methane cruciferous extract)||50mg|
|Curcumin extract 95%||200mg|
Inactive ingredients: Hypromellose (cellulose) vegetarian capsule shell (gelatine free), microcrystalline cellulose, magnesium stearate, magnesium silicate and silicon dioxide.
Store in a cool dry place below 25°C. Keep out of reach of children.
Indole-3-carbinol (I3C) and di-indole-methane (DIM) are believed to support the metabolism of certain hormones to their weaker and more benign metabolites. There is evidence that curcumin has anti-inflammatory effects that may protect cells from damage caused by inflammation and it also supports liver detoxification. Some evidence suggests that beta-sitosterol may inhibit 5 alpha-reductase, slowing the conversion of testosterone to dihydrotestosterone thereby supporting urinary flow and frequency of urination. Higher levels of lycopene and selenium have been associated with improved prostate health. Piperine is believed to increase bioavailability of a number of substances through a various mechanisms.
Men over 40 years of age:
Take 2 capsules daily or as directed by your medical practitioner. Take with or shortly after meals.
Do not use this product if you are hypersensitive (allergic) to any of the ingredients. If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy. Do not exceed recommended dosages unless on the advice of a healthcare practitioner. This medicine has not been evaluated by the Medicines Control Council. This medicine is not intended to diagnose, treat, cure or prevent any disease. Health supplements are intended only to complement health or supplement the diet.
Men with pre-existing prostate cancer should only use this product under the supervision of a medical practitioner.
Special precautions should be taken in the following cases:
Bile duct obstruction and gallstones: Curcumin can cause gallbladder contractions. Use with caution in individuals with gallstones or gallbladder disease.
Surgery: Curcumin has anti-platelet effects and may cause excessive bleeding perioperatively. Individuals should discontinue this product at least 2 weeks before elective surgical procedures.
Prostate cancer: There is contradictory research regarding the use of lycopene in prostate cancer. One study reported that lycopene might worsen established prostate cancer, while other studies have found it to be beneficial. Until more is known, use lycopene in men with established prostate cancer, with caution.
Side effects may include skin rash, nausea, diarrhoea, heartburn, vomiting, stomach cramps and bloating.
There are no known contraindications.
Cytochrome P450 1A2: Indole-3-carbinol induces the metabolism of CYP1A2 substrates and thus lower serum concentrations of medicines metabolised by this substrate. Medicines affected include clozapine, fluvoxamine, haloperidol, imipramine, olanzapine, pentazocine, propranolol, theophylline, zolmitriptan and others.
Warfarin and anticoagulants: Concomitant use of warfarin might increase the risk of bleeding due to decreased platelet aggregation and should be avoided or carefully monitored. Some of these medicines include aspirin, clopidogrel, dalteparin, enoxaparin, heparin, ticlopidine, warfarin, and others.
Ezetimibe: Ezetimibe inhibits intestinal absorption of beta-sitosterol and can reduce plasma concentrations of beta-sitosterol.
Pregnancy and Breastfeeding
Not intended for use in women.